ATE171950T1 - Faktor vii-peptide - Google Patents

Faktor vii-peptide

Info

Publication number
ATE171950T1
ATE171950T1 AT94918437T AT94918437T ATE171950T1 AT E171950 T1 ATE171950 T1 AT E171950T1 AT 94918437 T AT94918437 T AT 94918437T AT 94918437 T AT94918437 T AT 94918437T AT E171950 T1 ATE171950 T1 AT E171950T1
Authority
AT
Austria
Prior art keywords
pct
date
sec
peptides
factor vii
Prior art date
Application number
AT94918437T
Other languages
English (en)
Inventor
Ross Wentworth Stephens
Lars Orning
Kjell Steinar Sakariassen
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312601A external-priority patent/GB9312601D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of ATE171950T1 publication Critical patent/ATE171950T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94918437T 1993-06-18 1994-06-17 Faktor vii-peptide ATE171950T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939312601A GB9312601D0 (en) 1993-06-18 1993-06-18 Peptides
GB9409335A GB9409335D0 (en) 1993-06-18 1994-05-10 Peptides

Publications (1)

Publication Number Publication Date
ATE171950T1 true ATE171950T1 (de) 1998-10-15

Family

ID=26303086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918437T ATE171950T1 (de) 1993-06-18 1994-06-17 Faktor vii-peptide

Country Status (15)

Country Link
US (1) US5962418A (de)
EP (1) EP0703923B1 (de)
JP (1) JPH08511794A (de)
CN (1) CN1125450A (de)
AT (1) ATE171950T1 (de)
CA (1) CA2164422A1 (de)
CZ (1) CZ334095A3 (de)
DE (1) DE69413817T2 (de)
DK (1) DK0703923T3 (de)
FI (1) FI956055A7 (de)
HU (1) HUT74873A (de)
NO (1) NO955067D0 (de)
NZ (1) NZ267453A (de)
SK (1) SK156395A3 (de)
WO (1) WO1995000541A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GB9425381D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
GB9425380D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
US5837684A (en) * 1995-06-07 1998-11-17 Nycomed Imaging As Peptides
WO1999013062A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
WO1999013063A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
EP0987274A1 (de) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Faktor VIIa Inhibitore
AU5062100A (en) 1999-06-14 2001-01-02 Novo Nordisk A/S Fviia/tf activity inhibiting compounds
AU781618C (en) 1999-07-02 2006-03-16 Genentech Inc. FVIIa antagonists
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
DK3402537T3 (da) 2016-01-15 2021-03-29 Rigshospitalet Kvantitativ PET-afbildning af vævsfaktorekspression under anvendelse af 18-F mærket, aktiv positions-inhiberet faktor VII
WO2018091058A1 (en) 2016-11-17 2018-05-24 Rigshospitalet 177-lu labeled active site inhibited factor vii

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
CA1298033C (en) * 1985-04-16 1992-03-24 Takaharu Tanaka Dipeptide derivative of fatty acid
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
WO1990003390A1 (en) * 1988-09-23 1990-04-05 Corvas, Inc. Peptidyl inhibitors of the initiation of coagulation
ATE180834T1 (de) * 1990-01-29 1999-06-15 Zymogenetics Inc Antikoagulierende proteine
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
WO1993009804A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation

Also Published As

Publication number Publication date
FI956055L (fi) 1996-01-26
CN1125450A (zh) 1996-06-26
JPH08511794A (ja) 1996-12-10
DE69413817T2 (de) 1999-06-10
DE69413817D1 (de) 1998-11-12
AU691814B2 (en) 1998-05-28
AU6975594A (en) 1995-01-17
CZ334095A3 (en) 1996-07-17
US5962418A (en) 1999-10-05
SK156395A3 (en) 1996-06-05
NZ267453A (en) 1997-03-24
NO955067L (no) 1995-12-14
FI956055A7 (fi) 1996-01-26
CA2164422A1 (en) 1995-01-05
EP0703923A1 (de) 1996-04-03
HU9503593D0 (en) 1996-02-28
EP0703923B1 (de) 1998-10-07
WO1995000541A1 (en) 1995-01-05
DK0703923T3 (da) 1999-06-21
HUT74873A (en) 1997-02-28
NO955067D0 (no) 1995-12-14
FI956055A0 (fi) 1995-12-15

Similar Documents

Publication Publication Date Title
DE69413817D1 (de) Faktor vii-peptide
IL129238A0 (en) N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
EP0456152A3 (en) Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
SE0002202D0 (sv) New peptides
MY135057A (en) Dolastatin 15 derivatives
WO2000012541A3 (en) Cytotoxic peptides modified by bulky or lipophilic moieties
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
AU8649101A (en) Integrin binding motif containing peptides and methods of treating skeletal diseases
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
DK1313440T3 (da) Dentalprodukter indeholdende knoglevækstforögende peptider
KR910018404A (ko) 혈소판-응집 억제제
DE69426569D1 (de) Bivalente thrombininhibitore
KR910007960A (ko) 항응고성 펩티드
CA2419423A1 (en) Conjugates of peptides and peptide mimetics having integrin inhibitor properties
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
DE69922150D1 (de) Deoxyhypusin reagenz und peptide
WO2000027374A3 (en) The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee